- The valuation of 287 out of India’s top 500 most
valuable companies declined between October 2022 and April 2023. - India’s most valuable unlisted entity,
Serum Institute of India shed 12.6% of its value as the need for Covid-19 vaccines waned. - The top loser amongst the most valuable unlisted entities is
Byju’s , which saw 62% of its wealth destroyed.
Of the 500 companies, 287 experienced a decline in total value, while 14 remained flat, and 24 dropped out of the list. The combined value of the top 10 companies remained flat at ₹71.4 lakh crore, representing a significant portion of India's GDP.
“During this period, the Burgundy Private Hurun India 500 companies underperformed compared to major indices such as
Adani group saw its value decrease by half and two of the group companies – Adani Enterprises and Adani Total Gas – moved out of the top 10 during the period under review.
The outliers to the general trend were companies like ITC, HDFC and HDFC Bank, which became top gainers by absolute value.
Burgundy Private Hurun India 500-Special Report Top 10
Source: Hurun Research Institute, Burgundy Private Hurun India 500-Special Report
Unlisted companies aren’t spared
While top startups that went public have been losing value, their unlisted peers have also underperformed in the period under review. The top loser amongst the most valuable unlisted entities is Byju’s, which saw 62% of its wealth destroyed.
While Dream11 and Razorpay held on to their valuations, Swiggy shed 34% of its value. Their listed peers – also unicorns – haven’t done so well either – the combined value of Nykaa, Zomato, Paytm and Policybazaar declined by ₹7,872 crore during the review period.
“We are witnessing a unique confluence of events, with the Russia-Ukraine war causing a surge in inflationary pressures worldwide, central banks increasing their key lending rates and funding winter for startups,” said Junaid.
Eight out of the top 10 most valuable unlisted companies saw an erosion in their value. India’s most valuable unlisted entity, Serum Institute of India shed 12.6% of its value — as the need for Covid-19 vaccines waned.
Mumbai-based
Source: Hurun Research Institute, Burgundy Private Hurun India 500-Special Report